MasterPharm Minoxidil/Biotin/Spironolactone Capsules Recall: Elevated Drug Content
MasterPharm recalls compounded minoxididil/biotin/spironolactone capsules due to elevated drug levels. This compounded drug (not for resale) may pose risks from high minoxidil content. Consumers should contact the manufacturer for details.
“MasterPharm Minoxidil/Biotin/Spironolactone Capsules Recall: Elevated Drug Content.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37060-masterpharm-minoxidil-biotin-spironolactone-capsules-recall-elevated-drug-content. Based on FDA recall #D-1363-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1363-2020%22&limit=1).
The FDA announced on June 9, 2020, that MasterPharm LLC voluntarily recalled Minoxidil/Biotin/Spironolactone capsules due to elevated levels of minoxidil and biotin. The Class I recall affects 300 capsules distributed in Florida and Maryland.
How to tell if you have it
Brand: MasterPharm
Product: Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle
Lot #: 01-09-2020:13@8
Expiration Date: 7/7/2020
Quantity: 300 capsules
Distribution: FL and MD
The hazard
The recall was initiated because the compounded drug contained an elevated presence of minoxidil and biotin. The FDA classified this as a Class I recall, indicating a serious health risk.
Context
GovInfoNow's records show MasterPharm LLC has two other recalls on record since April 14, 2020. On July 2, 2020, the company issued a recall for Progesterone Troches due to lack of processing controls. Other recent recalls of similar products include Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Zydus Erythromycin Tablets Recall (April 29, 2026), and Asclemed Duloxetine Capsules Recall (May 14, 2026).
How to tell if you have this one
Check for the product name 'Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule' with 90 capsules per bottle. The lot number 01-09-2020:13@8 and expiration date 7/7/2020 are specific identifiers for this recall.
Brand
MasterPharm
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Manufacturer
Reach out to MasterPharm at 115-02 Liberty Ave, Richmond Hill, NY 11419 for specific guidance on the recall.
Where it went and when
Where it was distributed
Distributed in Florida and Maryland.
Listed by the agency
Not listed
FDA distribution: “FL and MD” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Maryland.
Recall timeline
FDA terminated this recall 3.4 years after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1363-2020 (June 9, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1363-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.